Literature DB >> 17581638

The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.

Min Peng1, Rachel Litman, Jenny Xie, Sudha Sharma, Robert M Brosh, Sharon B Cantor.   

Abstract

FANCJ also called BACH1/BRIP1 was first linked to hereditary breast cancer through its direct interaction with BRCA1. FANCJ was also recently identified as a Fanconi anemia (FA) gene product, establishing FANCJ as an essential tumor suppressor. Similar to other FA cells, FANCJ-null (FA-J) cells accumulate 4N DNA content in response to DNA interstrand crosslinks (ICLs). This accumulation is corrected by reintroduction of wild-type FANCJ. Here, we show that FANCJ interacts with the mismatch repair complex MutLalpha, composed of PMS2 and MLH1. Specifically, FANCJ directly interacts with MLH1 independent of BRCA1, through its helicase domain. Genetic studies reveal that FANCJ helicase activity and MLH1 binding, but not BRCA1 binding, are essential to correct the FA-J cells' ICL-induced 4N DNA accumulation and sensitivity to ICLs. These results suggest that the FANCJ/MutLalpha interaction, but not FANCJ/BRCA1 interaction, is essential for establishment of a normal ICL-induced response. The functional role of the FANCJ/MutLalpha complex demonstrates a novel link between FA and MMR, and predicts a broader role for FANCJ in DNA damage signaling independent of BRCA1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581638      PMCID: PMC1914102          DOI: 10.1038/sj.emboj.7601754

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  Immunoaffinity purification of mammalian protein complexes.

Authors:  Yoshihiro Nakatani; Vasily Ogryzko
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

Authors:  Marieke Levitus; Martin A Rooimans; Jûrgen Steltenpool; Nicolle F C Cool; Anneke B Oostra; Christopher G Mathew; Maureen E Hoatlin; Quinten Waisfisz; Fré Arwert; Johan P de Winter; Hans Joenje
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

3.  A simple diagnostic test for Fanconi anemia by flow cytometry.

Authors:  R Miglierina; M Le Coniat; R Berger
Journal:  Anal Cell Pathol       Date:  1991-03       Impact factor: 2.916

4.  Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.

Authors:  D R Duckett; J T Drummond; A I Murchie; J T Reardon; A Sancar; D M Lilley; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

5.  The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.

Authors:  G M Kupfer; A D D'Andrea
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

6.  ATR couples FANCD2 monoubiquitination to the DNA-damage response.

Authors:  Paul R Andreassen; Alan D D'Andrea; Toshiyasu Taniguchi
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

7.  The cell cycle of lymphocytes in Fanconi anemia.

Authors:  B Dutrillaux; A Aurias; A M Dutrillaux; D Buriot; M Prieur
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

8.  Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment.

Authors:  T N Kaiser; A Lojewski; C Dougherty; L Juergens; E Sahar; S A Latt
Journal:  Cytometry       Date:  1982-03

9.  Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.

Authors:  N de Wind; M Dekker; A Berns; M Radman; H te Riele
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

10.  Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.

Authors:  Sheila Seal; Deborah Thompson; Anthony Renwick; Anna Elliott; Patrick Kelly; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Munaza Ahmed; Katarina Spanova; Bernard North; Lesley McGuffog; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-10-08       Impact factor: 38.330

View more
  102 in total

1.  Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass.

Authors:  J Xie; R Litman; S Wang; M Peng; S Guillemette; T Rooney; S B Cantor
Journal:  Oncogene       Date:  2010-02-22       Impact factor: 9.867

2.  An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy.

Authors:  Jenny Xie; Shawna Guillemette; Min Peng; Candace Gilbert; Andrew Buermeyer; Sharon B Cantor
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

3.  Making sense of missense in Lynch syndrome: the clinical perspective.

Authors:  Henry T Lynch; Thomas Jascur; Stephen Lanspa; C Richard Boland
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

4.  FANCJ uses its motor ATPase to destabilize protein-DNA complexes, unwind triplexes, and inhibit RAD51 strand exchange.

Authors:  Joshua A Sommers; Nina Rawtani; Rigu Gupta; Dmitry V Bugreev; Alexander V Mazin; Sharon B Cantor; Robert M Brosh
Journal:  J Biol Chem       Date:  2009-01-16       Impact factor: 5.157

5.  Mismatch repair protein hMSH2-hMSH6 recognizes mismatches and forms sliding clamps within a D-loop recombination intermediate.

Authors:  Masayoshi Honda; Yusuke Okuno; Sarah R Hengel; Juana V Martín-López; Christopher P Cook; Ravindra Amunugama; Randal J Soukup; Shyamal Subramanyam; Richard Fishel; Maria Spies
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

6.  FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability.

Authors:  Yuliang Wu; Kazuo Shin-ya; Robert M Brosh
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

Review 7.  Fanconi anaemia and the repair of Watson and Crick DNA crosslinks.

Authors:  Molly C Kottemann; Agata Smogorzewska
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

8.  BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.

Authors:  Jianqiu Zou; Deli Zhang; Guang Qin; Xiangming Chen; Hongmin Wang; Dong Zhang
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  What is wrong with Fanconi anemia cells?

Authors:  Sharon B Cantor; Robert M Brosh
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  FANCJ helicase operates in the Fanconi Anemia DNA repair pathway and the response to replicational stress.

Authors:  Yuliang Wu; Robert M Brosh
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.